Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bundamedik Tbk (BMHS) vs Champion Pacific Indonesia Tbk. (IGAR)

Bundamedik TbkTrading
Champion Pacific Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bundamedik Tbk dan Champion Pacific Indonesia Tbk.: Bundamedik Tbk diperdagangkan di Rp176 (kapitalisasi pasar 1,51 T, volume 24 jam 536,7 rb), sedangkan Champion Pacific Indonesia Tbk. diperdagangkan di Rp414 (kapitalisasi pasar 384,1 M, volume 24 jam 16,2 rb). Perbedaan utamanya: Bundamedik Tbk jauh lebih besar — sekitar 3,9× kapitalisasi pasar Champion Pacific Indonesia Tbk., dan Bundamedik Tbk lebih aktif diperdagangkan (536,7 rb vs 16,2 rb). Mana yang lebih baik tergantung tujuan investasimu.

BMHSIGAR
Kapitalisasi Pasar
1,51 T384,1 M
Volume
536,7 rb16,2 rb
Lot
5,37 rb162
Perputaran
93,41 jt6,65 jt
Harga Rata-rata
174,05410,64
Nilai Transaksi
93,41 jt6,65 jt
Harga Ekuilibrium Indikatif
176414
Volume Ekuilibrium Indikatif
1001

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

BMHS
Lihat detail
IGAR
Lihat detail

Tentang Bundamedik Tbk

PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.

Selengkapnya di halaman BMHS

Tentang Champion Pacific Indonesia Tbk.

PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.

Selengkapnya di halaman IGAR